Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116849682 | 11684968 | 2 | F | 20000609 | 20160825 | 20151030 | 20160825 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-15158538 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160825 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116849682 | 11684968 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Unknown | U | 20972 | CAPSULE, HARD | |||||||||
116849682 | 11684968 | 2 | C | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
116849682 | 11684968 | 1 | HIV infection |
116849682 | 11684968 | 2 | HIV infection |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
116849682 | 11684968 | Live birth | |
116849682 | 11684968 | Maternal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |